Bel Fuse (BELFA) Reports Q4 EPS of $0.31
Get Alerts BELFA Hot Sheet
Price: $242.89 +3.16%
Financial Fact:
Dividends paid per share -common share: 0.06
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Dividends paid per share -common share: 0.06
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Bel Fuse (NASDAQ: BELFA) reported Q4 EPS of $0.31, versus $0.33 reported last year. Revenue for the quarter came in at $118.5 million, versus $135.2 million reported last year.
Fourth Quarter 2016 Highlights
- Net sales were $118.5 million for the fourth quarter of 2016, representing a 12.4% decline from $135.2 million in the fourth quarter of 2015.
- Gross profit margin improved to 20.7% in the fourth quarter of 2016, up from 19.3% in the fourth quarter of 2015.
- Net earnings increased to $3.4 million in the fourth quarter of 2016 compared to $2.9 million in the same period of 2015.
- The fourth quarter 2016 results were favorably impacted by foreign currency gains of $2.7 million (compared to foreign currency losses of $0.5 million in the fourth quarter of 2015) and a $1.0 million gain on sale of our San Diego property. These factors were offset by $1.5 million in restructuring charges (compared to $0.8 million in the same period of 2015) and an increase in our effective tax rate during the quarter to 46.9% (compared to 9.4% during the fourth quarter of 2015).
- Class A EPS was $0.27 on a GAAP basis (compared to $0.23 in the fourth quarter of 2015) and $0.31 on a Non-GAAP basis (compared to $0.33 in the fourth quarter of 2015).
- Class B EPS was $0.29 on a GAAP basis (compared to $0.25 in the fourth quarter of 2015) and $0.33 on a Non-GAAP basis (compared to $0.35 in the fourth quarter of 2015).
For earnings history and earnings-related data on Bel Fuse (BELFA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share